SEVERE APLASTIC ANEMIA, RELAPSE

Clinical trials for SEVERE APLASTIC ANEMIA, RELAPSE explained in plain language.

Never miss a new study

Get alerted when new SEVERE APLASTIC ANEMIA, RELAPSE trials appear

Sign up with your email to follow new studies for SEVERE APLASTIC ANEMIA, RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental drug targets bone marrow failure

Disease control Not yet recruiting

This study tests an experimental drug called dibotatug (DR-01) in adults with bone marrow failure syndromes, including severe aplastic anemia. The goal is to see if the drug is safe and can improve blood cell counts. Participants receive dibotatug by IV infusion, and researchers …

Matched conditions: SEVERE APLASTIC ANEMIA, RELAPSE

Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

SEVERE APLASTIC ANEMIA, RELAPSE

Get alerted when new SEVERE APLASTIC ANEMIA, RELAPSE trials appear

Experimental drug targets bone marrow failure